RecruitingNot ApplicableNCT06718842

Walking Program in Fatty Liver Children With Phenylketonuria

Walking Program in Fatty Liver Children With Phenylketonuria: Response of Liver Enzymes


Sponsor

Cairo University

Enrollment

40 participants

Start Date

Sep 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver


Eligibility

Min Age: 9 YearsMax Age: 12 Years

Inclusion Criteria3

  • PKU children
  • obese children
  • fatty liver children (non-alcoholic fatty liver)

Exclusion Criteria4

  • cardiac children
  • diabetic children
  • neurogenic disorders
  • respiratory and renal problems

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALwalking free online supervised program

this Group I will include PKU children sufferers (n=20) with non-alcoholic fatty liver that will perform walking program (online supervised free walking that will be applied daily for eight weeks)


Locations(1)

Cairo University

Dokki, Giza Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06718842


Related Trials